Editor’s note: A recording of this conversation is embedded below.
Last year saw a significant slowdown for 23andMe’s spit kit sales — and while business has picked back up during the pandemic, sales still haven’t rebounded to the level they were at in 2018 or even 2019, the company’s CEO Anne Wojcicki told STAT.
About the Author Reprints
